These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 19183783)

  • 1. The role of duloxetine in the treatment of anxiety disorders.
    De Berardis D; Serroni N; Carano A; Scali M; Valchera A; Campanella D; D'Albenzio A; Di Giuseppe B; Moschetta FS; Salerno RM; Ferro FM
    Neuropsychiatr Dis Treat; 2008 Oct; 4(5):929-35. PubMed ID: 19183783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is there a role for agomelatine in the treatment of anxiety disorders?A review of published data.
    De Berardis D; Conti CM; Marini S; Ferri F; Iasevoli F; Valchera A; Fornaro M; Cavuto M; Srinivasan V; Perna G; Carano A; Piersanti M; Martinotti G; Di Giannantonio M
    Int J Immunopathol Pharmacol; 2013; 26(2):299-304. PubMed ID: 23755745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin and Norepinephrine Reuptake Inhibitors.
    Shelton RC
    Handb Exp Pharmacol; 2019; 250():145-180. PubMed ID: 30838456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in Pharmacotherapy for Pediatric Anxiety Disorders.
    Nicotra CM; Strawn JR
    Child Adolesc Psychiatr Clin N Am; 2023 Jul; 32(3):573-587. PubMed ID: 37201968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duloxetine for the treatment of generalized anxiety disorder: a review.
    Khan AY; Macaluso M
    Neuropsychiatr Dis Treat; 2009; 5():23-31. PubMed ID: 19557096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin noradrenaline reuptake inhibitors: A new generation of treatment for anxiety disorders.
    Baldwin DS
    Int J Psychiatry Clin Pract; 2006; 10 Suppl 2():12-5. PubMed ID: 24921677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SNRIs pharmacological alternatives for the treatment of obsessive compulsive disorder?
    Sansone RA; Sansone LA
    Innov Clin Neurosci; 2011 Jun; 8(6):10-4. PubMed ID: 21779536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duloxetine in the treatment of generalized anxiety disorder.
    Wright A; Vandenberg C
    Int J Gen Med; 2009 Dec; 2():153-62. PubMed ID: 20360899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin noradrenaline reuptake inhibitors: Logical evolution of antidepressant development.
    Montgomery S
    Int J Psychiatry Clin Pract; 2006; 10 Suppl 2():5-11. PubMed ID: 24921676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychopharmacology of anxiety disorders.
    Cassano GB; Baldini Rossi N; Pini S
    Dialogues Clin Neurosci; 2002 Sep; 4(3):271-85. PubMed ID: 22033867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duloxetine in Psychiatric Disorders: Expansions Beyond Major Depression and Generalized Anxiety Disorder.
    Muscatello MRA; Zoccali RA; Pandolfo G; Mangano P; Lorusso S; Cedro C; Battaglia F; Spina E; Bruno A
    Front Psychiatry; 2019; 10():772. PubMed ID: 31749717
    [No Abstract]   [Full Text] [Related]  

  • 12. The pharmacologic treatment of anxiety disorders: a review of progress.
    Ravindran LN; Stein MB
    J Clin Psychiatry; 2010 Jul; 71(7):839-54. PubMed ID: 20667290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options.
    Garakani A; Murrough JW; Freire RC; Thom RP; Larkin K; Buono FD; Iosifescu DV
    Front Psychiatry; 2020; 11():595584. PubMed ID: 33424664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duloxetine in affective disorders: a naturalistic study on psychiatric and medical comorbidity, use in association and tolerability across different age groups.
    Dell'osso B; Camuri G; Dobrea C; Buoli M; Serati M; Altamura AC
    Clin Pract Epidemiol Ment Health; 2012; 8():120-5. PubMed ID: 23166563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duloxetine in the treatment of generalized anxiety disorder.
    Kornstein SG; Russell JM; Spann ME; Crits-Christoph P; Ball SG
    Expert Rev Neurother; 2009 Feb; 9(2):155-65. PubMed ID: 19210191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paroxetine treatment of generalized anxiety disorder.
    Sheehan DV; Mao CG
    Psychopharmacol Bull; 2003; 37 Suppl 1():64-75. PubMed ID: 14566202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duloxetine in the treatment of major psychiatric and neuropathic disorders.
    Müller N; Schennach R; Riedel M; Möller HJ
    Expert Rev Neurother; 2008 Apr; 8(4):527-36. PubMed ID: 18416656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paroxetine: an update of its use in psychiatric disorders in adults.
    Wagstaff AJ; Cheer SM; Matheson AJ; Ormrod D; Goa KL
    Drugs; 2002; 62(4):655-703. PubMed ID: 11893234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-Antidepressant Treatment of Generalized Anxiety Disorder.
    Zahreddine N; Richa S
    Curr Clin Pharmacol; 2015; 10(2):86-96. PubMed ID: 23438725
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.